MRK vs HSIC
By Alex · Tickerpine
Merck & Co., Inc. vs Henry Schein, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | HSIC |
|---|---|---|
| Price | $148.69 | $85.99 |
| Market cap | $366.84B | $9.58B |
| P/E ratio | 119.0 | 25.2 |
| ROE | 6.96% | 8.85% |
| Profit margin | 4.77% | 2.96% |
| Revenue growth | 5.10% | 6.70% |
| Dividend yield | 2.29% | — |
| Beta | 0.23 | 0.81 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs HSIC in plain English
- MRK is the bigger company — about 38.3× the market cap of HSIC.
- HSIC is cheaper on earnings (P/E 25.2 vs 119.0).
- HSIC earns a higher return on equity (9% vs 7%).
- HSIC is growing revenue faster (7% vs 5%).
- MRK pays a dividend (2.29%) while the other effectively doesn't.
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
HSIC return calculator
See what $1,000 in Henry Schein, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.